ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis [Yahoo! Finance]
Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arcutis Announces Promotions on Executive Management Team [Yahoo! Finance]
Form 144 Arcutis Biotherapeutics, Filed by: Watanabe Todd Franklin
Form 4 Arcutis Biotherapeutics, For: May 31 Filed by: Matsuda Masaru
Form 4 Arcutis Biotherapeutics, For: May 31 Filed by: Watanabe Todd Franklin
Form 4 Arcutis Biotherapeutics, For: Dec 02 Filed by: Welgus Howard G.
Form 4 Arcutis Biotherapeutics, For: Nov 30 Filed by: Edwards Larry Todd
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.